Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Gastroenterology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
AI Models Combine Genomics and Demographics to Predict Gastric Cancer Risk
February 2026
New research shows supervised machine learning models combining Helicobacter pylori genomic data with patient demographics can accurately predict gastric cancer risk.
Read more
13 Nov 2017
Significant Mortality Benefits of Mechanical Valves
MECHANICAL valves have very good long-term mortality benefits and should be used more often, particularly in younger patients who require mitral-valve…
7 Nov 2017
Genetic Predictors for Oesophageal Cancer Identified in High-Risk Patients
OESOPHAGEAL cancer could be diagnosed up to 8 years before the first symptoms appear, enabling earlier treatment of the condition, according to…
10 Oct 2017
RedHill Biopharma Announces Positive Top-Line Results from Phase II Study of BEKINDA® in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Tel-Aviv, Israel/Raleigh, NC, USA, 03 October, 2017 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“Red Hill” or the “Company”)…
3 Oct 2017
Studying Protein Networks in Bowel Cancer
PROTEOMIC study of bowel cancer cells identifies common protein mutations and allows the prediction of treatment response….
3 Oct 2017
Role of Gut Bacteria as a Parkinson’s Disease Biomarker
BACTERIAL communities in the gut of Parkinson’s patients differ to those of healthy people, potentially providing an early indicator of the…
19 Sep 2017
RedHill Biopharma Initiates Promotion of Esomeprazole Strontium Delayed-Release Capsules 49.3 mg in the U.S.
RedHill Biopharma Ltd. announced that it has initiated promotion of Esomeprazole Strontium Delayed-Release (DR) Capsules 49.3 mg1 in the U.S.
28 Jul 2017
Why the Doctors’ Mantra Is Killing Them
It’s a deadly secret that many of us keep inside. It’s a burden that only we can feel, while acting completely unaffected to the outside world.
18 Jul 2017
RedHill Biopharma Announces Last Patient Visit in BEKINDA® Phase II Study for IBS-D
Tel-Aviv, Israel / Raleigh, NC, USA, 17 July, 2017 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”)…
Loading posts...
« Previous
1
…
33
34
35
36
37
…
42
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View